CD71+ erythroid cells as a potential early biomarker for hemodynamic significant patent ductus arteriosus in preterm infants

IntroductionHemodynamically significant patent ductus arteriosus (hsPDA) in preterm infants is associated with increased mortality and morbidity. Early and accurate identification of infants at risk for PDA is critical for improving outcome. Perinatal inflammation is a known risk factor of PDA. CD71...

Description complète

Détails bibliographiques

Auteurs principaux:	Ju Ae Shin, Jae Young Lee, Jeongmin Shin, Min Soo Kim, Young-Ah Youn, Joungok Kim, Eun-Jee Oh, Jin-Hee Oh
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-01-01
Collection:	Frontiers in Immunology
Sujets:	CD71+ erythroid cell hemodynamically significant patent ductus arteriosus immunoregulation patent ductus arteriosus preterm infants
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1738166/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!